The lack of effect on QoL and oxygen consumption help cement the idea that the disease isn’t the same as obstructive HCM.

In patients with gastrointestinal cancers treated with fluoropyrimidine-based chemotherapy agents, better overall survival at 1 year offsets a small increase in their risk of CV events, new data ...